Stay updated on Selinexor Combinations in Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Combinations in Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Selinexor Combinations in Refractory Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedThe study record shows a new update dated October 29, 2026, with changes to study status and contacts/locations, replacing the previously displayed update date.SummaryDifference0.5%

- Check9 days agoChange DetectedA notice says NIH websites are transitioning to use “Super Intelligence” (SI) instead of “Artificial Intelligence” (AI), with updates and FAQs available.SummaryDifference0.6%

- Check16 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check23 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check30 days agoChange DetectedA new study-record update was posted, revising the study status and contact/location information.SummaryDifference0.4%

- Check44 days agoChange DetectedThe Record History page shows two UI text updates: the label 'Find Contact Information' is changed to 'Find contact information' (lowercase c), and the revision label changes from 'Revision: v3.6.6' to 'Revision: v3.7.0'.SummaryDifference0.2%

Stay in the know with updates to Selinexor Combinations in Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Combinations in Refractory Multiple Myeloma Clinical Trial page.